FDA Transparency
More Information on FDA Transparency
- Letter to the FDA Calling for Full Transparency Regarding Coronavirus-Related Drug Shortages, March 3, 2020
- Letter to Pharmaceutical Industry Trade Groups Calling for Full Transparency Regarding Coronavirus-Related Drug Shortages, March 3, 2020
- Comments on the FDA’s Proposal to Change the Approval Package Documentation Posted on the Agency’s Website For New Drugs and Biologics, August 26, 2019
- Panel Presentation at the Johns Hopkins University Bloomberg School of Public Health Symposium: Transparency at the U.S. Food and Drug Administration, January 16, 2018
- Commentary Advocating That the FDA Disclose Information Related to Rejected or Withdrawn New Drug Applications, January 16, 2018
- Comments on FDA Transparency, July 20, 2010
- Comments on First Amendment Issues, September 13, 2002